|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 31/00 |
| (11) | Number of the document | 1474436 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03704541.6 |
| Date of filing the European patent application | 2003-02-03 | |
| (97) | Date of publication of the European application | 2004-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2009-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2003/001115 |
| Date | 2003-02-03 |
| (87) | Number | WO 2003/066653 |
| Date | 2003-08-14 |
| (30) | Number | Date | Country code |
| 0202564 | 2002-02-04 | GB |
| (72) |
Coote, Steven John, GB
Nice, Rosalyn Kay, GB
Wipperman, Mark David, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PROCESS FOR THE PRODUCTION OF FLUTICASONE PROPIONATE, IN PARTICULAR OF POLYMORPHIC FORM 1 |
| PROCESS FOR THE PRODUCTION OF FLUTICASONE PROPIONATE, IN PARTICULAR OF POLYMORPHIC FORM 1 |